======= IL31RA =======
== Gene Information ==
* **Official Symbol**: IL31RA
* **Official Name**: interleukin 31 receptor A
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=133396|133396]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8NI17|Q8NI17]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=IL31RA&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IL31RA|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609510|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene belongs to the type I cytokine receptor family. This receptor, with homology to gp130, is expressed on monocytes, and is involved in IL-31 signaling via activation of STAT-3 and STAT-5. It functions either as a monomer, or as part of a receptor complex with oncostatin M receptor (OSMR). Several alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Jun 2011].
* **UniProt Summary**: N/A
|fn3|
|IL6Ra-bind|
|EpoR lig-bind|
|negative regulation of macrophage activation|
|monocyte differentiation|
|mononuclear cell differentiation|
|macrophage differentiation|
|receptor signaling pathway via JAK-STAT|
|receptor signaling pathway via STAT|
|cytokine binding|
|cytokine receptor activity|
|regulation of macrophage activation|
|positive regulation of tyrosine phosphorylation of STAT protein|
|presynaptic membrane|
|regulation of tyrosine phosphorylation of STAT protein|
|positive regulation of receptor signaling pathway via JAK-STAT|
|positive regulation of receptor signaling pathway via STAT|
|myeloid leukocyte differentiation|
|regulation of receptor signaling pathway via JAK-STAT|
|regulation of receptor signaling pathway via STAT|
|negative regulation of leukocyte activation|
|positive regulation of peptidyl-tyrosine phosphorylation|
|negative regulation of cell activation|
|receptor complex|
|myeloid cell differentiation|
|regulation of peptidyl-tyrosine phosphorylation|
|transcription coactivator activity|
|axon|
|leukocyte differentiation|
|MAPK cascade|
|signal transduction by protein phosphorylation|
|external side of plasma membrane|
|negative regulation of immune system process|
|protein kinase binding|
|transmembrane receptor protein tyrosine kinase signaling pathway|
|cell junction|
|hemopoiesis|
|regulation of leukocyte activation|
|hematopoietic or lymphoid organ development|
|regulation of cell activation|
|immune system development|
|cytokine-mediated signaling pathway|
|enzyme linked receptor protein signaling pathway|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|positive regulation of cell population proliferation|
|protein phosphorylation|
|negative regulation of cell death|
|cellular response to cytokine stimulus|
|positive regulation of protein phosphorylation|
|positive regulation of phosphorylation|
|response to cytokine|
|positive regulation of phosphate metabolic process|
|positive regulation of phosphorus metabolic process|
|positive regulation of protein modification process|
|phosphorylation|
|defense response|
|regulation of protein phosphorylation|
|positive regulation of transcription, DNA-templated|
|regulation of apoptotic process|
|regulation of programmed cell death|
|regulation of phosphorylation|
|positive regulation of cellular protein metabolic process|
|regulation of cell population proliferation|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|homeostatic process|
|positive regulation of signal transduction|
|regulation of immune system process|
|regulation of cell death|
|intracellular signal transduction|
|positive regulation of protein metabolic process|
|positive regulation of RNA metabolic process|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of protein modification process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|1.76|
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|1.93|
|[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|2.06|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12005
* **Expression level (log2 read counts)**: -0.68
{{:chemogenomics:nalm6 dist.png?nolink |}}